QID 376433

Date Published: 2022-03-01

QID 376433: McAfee Agent Multiple Vulnerabilities (SB10378)

The McAfee Agent is the distributed component of McAfee ePolicy Orchestrator. It downloads and enforces policies, and executes client-side tasks such as deployment and updating. The Agent also uploads events and provides additional data regarding each system status.

McAfee Agent is affected with the following vulnerability:
CVE-2021-31854: A command Injection Vulnerability in McAfee Agent (MA) for Windows prior to 5.7.5 allows local users to inject arbitrary shell code into the file
CVE-2022-0166: A privilege escalation vulnerability in the McAfee Agent prior to 5.7.5 affecting all supported operating systems..
Affected versions:
McAfee Agent Prior to 5.7.5
QID Detection Logic(Authenticated):
The QID checks for vulnerable version of McAfee Agent by checking the version information at HKLM\SOFTWARE\McAfee\Agent registry key for 32/64 bit and /opt/McAfee/agent/bin/msaconfig in Linux to detect the version.

Successful exploitation of this vulnerability may result command injection and privilege escalation.

CVSS V3 rated as High - 7.8 severity.

CVSS V2 rated as Critical - 9.3 severity.

Solution

Install or update to McAfee Agent 5.7.5 For more details refer SB10378

Vendor References

SB10378 - kc.mcafee.com/corporate/index?page=content&id=SB10378

CVEs related to QID 376433

CVE-2021-31854 | CVE-2022-0166 |

Software Advisories

Advisory ID	Software	Component	Link
SB10378			kc.mcafee.com/corporate/index?page=content&id=SB10378

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].